Evidence map›Paper›PMID 36439564›Full record

ArticleCureus2022

Medication Adherence Among Multimorbid Patients With Polypharmacy and Its Relation to Social Support at National Guard Primary Health Care Centers, Riyadh.

Ahmed S Almutairi, Taghreed M Alhazmi, Yazeed H Alotaibi, Abdulmajeed A Alfraidi, Abdulaziz M Alsaad, Rashed A Matrood, Abdulmohsen N Al-Khatir, Abdulrahman A Alsubaie, Waleed M Alotibi

Abstract read
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ahmed S AlmutairiCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, SAU.
Taghreed M AlhazmiFamily Medicine and Primary Care, King Abdulaziz Medical City, Riyadh, SAU.
Yazeed H AlotaibiCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, SAU.
Abdulmajeed A AlfraidiCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, SAU.
Abdulaziz M AlsaadCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, SAU.
Rashed A MatroodCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, SAU.
Abdulmohsen N Al-KhatirCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, SAU.
Abdulrahman A AlsubaieCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, SAU.
Waleed M AlotibiCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of the present study was to estimate the prevalence of nonadherence to medication in multimorbid patients with polypharmacy and its relationship to social support in primary healthcare centers in Riyadh, Saudi Arabia.

methodsWe conducted a cross-sectional, convenience-sample, non-randomized study in three primary healthcare centers managed by National Guard Health Affairs. The participants included 417 adult patients - (a) with two or more chronic illnesses and (b) who were taking two or more medications. The primary outcome variable was the prevalence of medication nonadherence in multimorbid patients with polypharmacy as measured by the modified Morisky Medication Adherence Scale (MMAS-8). The second main variable was the impact of functional social support, as measured by the Duke-UNC Functional Social Support Questionnaire (FSSQ), on medication adherence.

resultsThe level of medication adherence was low for 194 (46.5%) of the 417 patients, medium for 127 (30.5%), and high for 96 (23%). There were 256 (61.4%) male participants and 161 (38.6%) females, and their mean age was 59.15 (SD ± 11.186) years. Additionally, 171 (41%) participants used two or three medications, 127 (30.5%) used four or five medications, and 119 (28.5%) used more than five medications; 178 (42.7%) of the patients had two comorbidities, 136 (32.9%) had three comorbidities, 69 (16.5%) had four comorbidities, and 31 (7.5%) had five comorbidities. Some social support data from the Duke-UNC Functional Social Support Questionnaire (FSSQ) was missing for 58 (13.9%) of the participants. Among the rest of the sample, reported levels of social support levels were high for 246 (59%) patients, medium for 101 (24.2%), and low for 12 (2.9%) patients. None of the differences between social support and medication adherence were statistically significant. However, 61 (24.8%) patients reported both high social support and high medication adherence; 173 (48.2%) had low social support and low medication adherence (p = 0.470).

conclusionWe found that medication nonadherence in multimorbid patients with polypharmacy was high (46.5%). Although there were no statistically significant relationships between social support and medication adherence, certain patient characteristics were associated with low medication adherence - age over 60 years, male gender, and number of medications.

Indexed as

adherencemedicationmultimorbiditypolypharmacysocial support

Identifiers

PMID36439564
PMCPMC9689831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.